跳至主要内容
临床试验/CTRI/2018/05/014336
CTRI/2018/05/014336已完成未知

Prospective study of vitrectomy with intravitreal dexamethasone implant for idiopathic epiretinal membrane

V Prasad Eye Institute0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.Patients with idiopathic epiretinal membrane.
  • b.Visual acuity < 20/30 and >20/400
  • c.Central macular thickness > 300 µs as per OCT confirmed diagnosis
  • d.Pseudophakic/ phakic patients
  • e.Duration since diagnosis < 1 yr

排除标准

  • a.Patient not willing to participate in the study
  • b.Epiretinal membrane secondary to other retinal diseases like diabetic retinopathy, vascular occlusions, uveitis, age related macular degeneration, which can cause macular edema and decreased visual acuity.
  • c.Aphakia, advanced glaucoma.
  • d.Patients with hazy media.
  • e.Advanced cataract or significant cataract that requires a cataract surgery within 1 year.
  • f.Duration since diagnosis > 1 year.
  • g.Epiretinal membrane with full thickness macular hole.
  • h.Previous vitreoretinal surgery in the study eye or anticipated surgery within 12 months of enrolment.
  • i.Previous pan retinal laser photocoagulation or macular laser photocoagulation in the study eye.
  • j.Use of intraocular or periocular corticosteroids in the study eye previously.
  • k.Previous treatment with anti-VEGF drugs in the study eye.

研究者

发起方
V Prasad Eye Institute

相似试验